Speakers


Check out the mini-curriculum, just click on the Speaker’s name:


International Speakers

Ashley Umlauf 
Ashley Umlauf
Ashley Umlauf é cientista de aplicações de campo de cultura celular e terapia celular II (FAS) da ThermoFisher Scientific. Ashley aproveita sua experiência significativa em projetar e desenvolver vários dispositivos médicos comercializados para atuar como consultora técnica primária para seus clientes de terapia celular e genética. Ashley possui um B.S. Graduada em Bioquímica e Biologia Molecular pela University of Wisconsin.

BENJAMIN P. KLEINSTIVER 
BENJAMIN P. KLEINSTIVER
ASSISTANT PROFESSOR, MASSACHUSETTS GENERAL HOSPITAL AND HARVARD MEDICAL SCHOOL.

BRUCE LEVINE 
BRUCE LEVINE
Barbara and Edward Netter Professor in Cancer Gene Therapy
University of Pennsylvania Perelman School of Medicine.
Specialty Division: Transfusion Medicine & Therapeutic Pathology
Research Expertise: Immunology, Cell and Gene Therapy
Other Expertise: Good Manufacturing Practices
Itmat Expertise: Dr. Levine's interests include cell, gene, and biologic therapy clinical trial development, manufacturing, and testing and lymphocyte growth, activation and senescence.
Education: B.A. (Major-Biology, Minor-History), The University of Pennsylvania , 1984
Ph.D. (Immunology and Infectious Diseases), The Johns Hopkins University, 1992
Specialty Certification: Postgraduate Training
Post-doctoral Fellow, Henry M. Jackson Foundation, Naval Medical Research Institute, National Naval Medical Center, Bethesda, MD, 1992-1996.

CARLOS JAVIER ALMECIGA DÍAZ 
CARLOS JAVIER ALMECIGA DÍAZ
Bacharel em Farmácia pela Universidad Nacional de Colombia e doutor em Ciências Biológicas pela Pontificia Universidad Javeriana. Professor Associado e Diretor do Instituto para o Estudo dos Erros Inatos do Metabolismo da Pontificia Universidad Javeriana. Eu trabalhei em terapia gênica para Morquio A usando AAV e vetores lentivirais, e atualmente estou explorando o uso de CRISPR / Cas9 como ferramenta de terapia gênica para vários erros inatos do metabolismo. Também trabalhei na produção e caracterização de cinco enzimas lisossomais recombinantes em microrganismos (bactérias e leveduras) para o desenvolvimento de novos ERTs. Também trabalhei na aplicação de ferramentas de bioinformática para o estudo dos erros inatos do metabolismo, como modelagem de proteínas, efeito de mutação, docking e biologia de sistemas.

CHARLES E. MURRY 
CHARLES E. MURRY
O Dr. Charles Murry recebeu seu diploma de bacharel em química pela University of North Dakota, seguido pelo treinamento de MD-PhD na Duke University, onde estudou lesão de isquemia-reperfusão miocárdica. Ele fez um treinamento de residência em Patologia na Universidade de Washington, seguido por um treinamento de bolsa em biologia vascular e diagnóstico de patologia cardiovascular. Atualmente é professor dos departamentos de Medicina Laboratorial e Patologia, Bioengenharia e Medicina / Cardiologia da Universidade de
Washington. A pesquisa de Murry concentra-se na biologia das células-tronco, com ênfase na compreensão da diferenciação do sistema cardiovascular humano e no uso dessas células para estudar doenças e regenerar tecidos danificados. Seu grupo é líder mundial em regeneração cardíaca e está trabalhando em um ensaio clínico com terapia com cardiomiócitos. Além de dirigir seu grupo de pesquisa, o Dr. Murry é o diretor do Instituto UW de Células-tronco e Medicina Regenerativa. Ele atuou em muitos comitês locais, nacionais e internacionais, falou amplamente sobre células-tronco e medicina cardiovascular e recebeu vários prêmios por ensino e realizações científicas. O Dr. Murry é membro do Conselho de Diretores do ISSCR e do Comitê de Tradução Clínica do ISSCR. Mais recentemente, Murry transferiu parte de seu grupo de pesquisa para a Sana Biotechnology, onde agora atua como vice-presidente sênior e diretor científico de terapia celular. Sua equipe em Sana está trabalhando para trazer a regeneração cardíaca baseada em células-tronco para os ensaios clínicos.

CLAUDIA DOS SANTOS 
CLAUDIA DOS SANTOS
Dr. dos Santos is a Scientist in the Keenan Research Center of the Li Ka Shing Knowledge Institute of St. Michael‘s Hospital and an Assistant Professor of Medicine, Department of Medicine, Division of Respirology and Interdepartmental Division of Critical Care at the University of Toronto.

She did her BSc Hons in Biology at Trent University, her MSc degree at the Hospital for Sick Children in Molecular and Medical Genetics where she worked with Dr. Manuel Buchwald on Fanconi’s Anemia and DNA repair and her Medical degree, Internal Medicine and Critical Care training at the University of Toronto. She continued in Toronto for her post-doc in the lab of Dr. Arthur Slutsky, a world renowned expert on mechanical ventilation and Dr. Mingyao Liu an expert on mechanotransduction.

Dr. dos Santos now holds an appointment at the Institute of Medical Sciences and Collaborative Program in Genome Biology and Bioinformatics. Her clinical specialty is Critical Care Medicine. She held a Fellowship from the Parker B. Francis Foundation, a Phase I Clinician-Scientist from the Heart and Stroke Foundation, and now holds an Early Research Award from the Ministry of Research and Innovation and a New Investigator Award from the Canadian Institutes of Health Research (CIHR).

CLAUDIO SPERA 
CLAUDIO SPERA
Trained Ophthalmologist, over 20 years in strategic Medical Affairs and recognised experience in launching and network building in gene therapy. Leading ocular gene at Novartis with strategic global medical leadership in the ocular gene portfolio. Close collaboration with key cross-functional stakeholders on the Ocular Gene therapies pipeline to shape the access and outcomes for patients with inherited retinal diseases and other blinding diseases, leveraging recognized experience in launching and network building in Gene Therapy.

DANIEL J. WEISS 
DANIEL J. WEISS
Professor of Medicine at University of Vermont College of Medicine.
I have had a longstanding interest in lung repair and regeneration after injury, notably gene and cell therapy approaches for lung diseases. In particular this has included developing novel techniques with which to investigate and enhance lung gene and cell therapies. Recent published work in cell therapy approaches for lung diseases has included several benchmark publications that have included the first ever trial of cell therapy for COPD and that have helped define whether exogenous cells can engraft in the lung. As such, I view myself as a translational scientist whose work spans from benchtop to clinical trials. I have also instituted a biennial meeting held at the University of Vermont, Stem Cells and Cell Therapies in Lung Biology and Diseases, that is widely viewed by the NIH, FDA, and non-profit Respiratory Disease Foundations as the major meeting in the field. My overall goal is to provide a firm scientific basis for clinical application of cell therapies in lung diseases. I have been funded by the NIH, DOD, non-profit Respiratory Disease Foundations, and by industry sources since 1995. Current work in the laboratory is focused in three major areas: 1) Bioengineering approaches for development of functional lung tissue; 2) Immunomodulation of lung inflammation by mesenchymal stromal cells (MSCs); 3) Development of cell therapy-based approaches for lung disease.

DAVID COURTMAN 
DAVID COURTMAN
Senior Investigator, Regenerative Medicine Program - Ottawa Hospital Research Institute.
Director, Cell Manufacturing, Biotherapeutics Core Facilities - Ottawa Hospital Research Institute.
Assistant Professor, Dept of Medicine, Faculty of Medicine - University of Ottawa.
Dr. Courtman has developed and assessed, both biologically and biomechanically, novel tissue, protein, and cell based biomaterials for use in vascular grafts and heart valves. He has made fundamental contributions to field of vascular pathobiology furthering our understanding of disease progression and tissue material interactions. More recently he has been instrumental in the development of a number of cellular based gene therapies for the treatment of cardio-pulmonary disorders taking them from initial concept, through appropriate animal disease models, and into first in man clinical trials. He is currently directing the manufacturing of these cell products for trials treating patients suffering from pulmonary arterial hypertension, myocardial infarction, and sepsis.

DONG-SEOK SOHN 
DONG-SEOK SOHN
Presidente e Professor do Departamento de Odontologia e Cirurgia Bucomaxilofacial da Escola de Medicina, Universidade Católica de Deagu, República da Coréia. Presidente e fundador do mundo
Academy of Ultrasonic Piezoelectric Bone Surgery (www.waups.org); Ex-presidente do ICOI Seção Ásia-Pacífico e presidente fundador da ICOI Coreia (Sociedade Coreana de Oral Implantologistas); Presidente do 9º Congresso da Seção Ásia-Pacífico do ICOI e presidente do Co-congresso da 28º Congresso Mundial ICOI e Congresso Mundial de Cirurgia Óssea Piezoelétrica Ultrassônica;
Criador e disseminador de muitas técnicas em medicina regenerativa, como osso em barra e enxerto dentário.

FABIANA ARZUAGA 
FABIANA ARZUAGA
Ministério da Ciência, Tecnologia e Inovação Produtiva Argentina.
Comissão Assessora em Medicina Regenerativa e Terapias Celulares.

GUILLERMO GRANDE 
GUILLERMO GRANDE
Ex Profesor de Clínica Equina FCV-UNL Actual Adscripto Graduado de Práctica Hospitalaria FCV-UNL.

HANNELE RUOHOLA-BAKER
HIRONORI NAKAGAMI
HUGO PELUFFO 
HUGO PELUFFO
Associate (Tenure) Professor Department of Histology and Embryology Faculty of Medicine Universidad de la República and
Principal Investigator Neuroinflammation and Gene Therapy Laboratory Institut Pasteur Montevideo Uuruguay.

Publications: https://pubmed.ncbi.nlm.nih.gov/?term=peluffo%2C+h&sort=date

JACQUES EDUARDO NÖR 
JACQUES EDUARDO NÖR
Chair Departamento Cardiology, Restorative Sciences, Endodontics, University of Michigan School of Dentistry; Professor de Otorrinolaringologia da Escola de Medicina da Universidade de Michigan; Professor de Engenharia Biomédica, University of Michigan College of Engineering; Professor de Odontologia da Escola de Odontologia da Universidade de Michigan; Presidente Eleito da American Association for Dental Research (AADR); Editor Associado, Journal of Dental Research; Membro: 29 Conselhos editoriais.

LESLEY FORRESTER 
LESLEY FORRESTER
PhD at University of Edinburgh on the clonality of the haematopoietic stem cell system. EMBO Postdoctoral fellowship in Toronto, Samuel Lunenfeld research institute with Alan Bernstein. – Here I got interested in generating blood from embryonic stem cells (4 years from 1989-1993). MRC Senior Fellowship to set up my own lab in Edinburgh where I have been ever since.

MANUELA E. GOMES 
MANUELA E. GOMES
Manuela E. Gomes is Associate Professor and President of the I3Bs Research Institute of the University of Minho, Portugal. Her research interests currently focus on tendon tissue engineering strategies, namely in the development of scaffold materials and bioinks based on biodegradable natural origin polymers, stem cells sourcing and differentiation (using biochemical and physical methods). She graduated in Metallurgical and Materials Engineering, University of Porto, Portugal in 1997, obtained a MSc in Polymer Engineering, Univ. of Minho in cooperation with the company Isotis, Bilthoven (Holland), and a PhD in Materials Science and Engineering – Tissue Engineering/Hybrid Materials in collaboration with the Rice University (USA), in 2005. She was a co-founder of the 3B’s Research Group and one of the vice-directors of the group since 2011. Manuela Gomes is a board member of the Doctoral Program on Tissue Engineering, Regenerative Medicine and Stem Cells and is responsible for lecturing on biomaterials, tissue engineering and stem cells to Biomedical Engineering students of the University of Minho. She has been participated in numerous European and national/regional projects as PI or team member. She was awarded a Consolidator Grant from the European Research Council (ERC CoG) to develop magnetically assisted tissue engineering technologies for tendon regeneration and with a EC funded Twinning Project – “Achilles: Overcoming specific weaknesses in tendon biology to design advanced regenerative therapies”, in collaboration with NUI Galway (Ireland), University Regensburg Medical Centre (Germany) and the Mayo Clinic (USA). Manuela Gomes is editor 2 books and co-editor of the Tissue Engineering Encyclopaedia (Elsevier, 2019) and author of 44 book chapters, 200 full papers published in international refereed journals, and more than 300 communications in international conferences (7.900 citations, H-index of 47). She has received several awards, including the 2013 Young Investigator Award of the Tissue Engineering and Regenerative Medicine International Society – European Chapter (TERMIS-EU). Manuela Gomes is an active member of several international scientific organizations, being currently a member-at -large and chair of the membership committee of TERMIS, and Portugal Ambassador for the EORS.

MARCELO PASQUINI 
MARCELO PASQUINI
Associate Professor of Medicine, Hematology-Oncology Division at the Medical College of Wisconsin and Attending Physician in the MCW Hematopoietic Cell Transplantation Program. Senior Scientific Director for Clinical Trials, CIBMTR. Scientific Director, CIBMTR Regimen‐Related Toxicity and Supportive Care Working Committee. Scientific Director, CIBMTR Autoimmune Diseases and Cellular Therapies Working Committee. Protocol Officer and Medical Monitor, Blood and Marrow Transplant Clinical Trials Network.

MARK J OSBORN 
MARK J OSBORN
Dr. Osborn is an Assistant Professor in the Department of Pediatrics, Division of Blood and Marrow Transplantation. He is also a member of the Cancer Center. Dr. Osborn received his PhD degree from the University of Minnesota in 2009 in the laboratory of Dr. Bruce R. Blazar, MD.

MAROUN KHOURY 
MAROUN KHOURY
Maroun Khoury is currently the Chief Scientific Officer of Cells for Cells and the co-founder of REGENERO: the Chilean Consortium for Regenerative Medicine. He also holds an associate Professor position at the Universidad of the Andes in Santiago, Chile. Maroun Khoury in the immediate past VP for the South and Central America for the International Society for Cellular Therapy (ISCT). He is the co-author of multiple preclinical studies in stem cells and clinical publications including a Phase I/II in heart failure and Osteoarthritis.

MASSIMO DOMINICI 
MASSIMO DOMINICI
Hematologist & oncologist with a strong attitude for research focused on cellular therapies for tissue regeneration and drug delivery. A constant attention to microenvironment cues and their role in influencing biological events in cancer and regenerative medicine. Combining clinical activities and lab, he leads 3 research teams of motivated PhD students and Post-docs to implement cell-gene therapy from the pre-clinic to the clinic. Twenty-nine grants form national and international public & private bodies in 15 years with more than 13 M€ of support. More than 140 peer-revised manuscripts published, 2 edited books, 4 book chapters and 10 patents. One start-up founded: @rigenerand that raised 12 M€ of funds in 3 years. He seeks to treat patients with cells. Currently chair of the @ISCTglobal task force on unproven cell and gene therapies #UnprovenCGT.

MATTHEW PORTEUS 
MATTHEW PORTEUS
PROFESSOR OF PEDIATRICS (STEM CELL TRANSPLANTATION) STANFORD UNIVERSITY, SCHOOL OF MEDICINE

MAURO AVANZI 
MAURO AVANZI
Vice President, Clinical Development at Neogene Therapeutics.

MILDRED C. EMBREE 
MILDRED C. EMBREE
Professor Assistente de Medicina Dentária em Ortodontia e Diretor do Laboratório de Biologia e Medicina Regenerativa da ATM da Universidade de Columbia. Dr. Embree é um ortodontista e celular biólogo com mais de 15 anos de experiência na área de osteoartrite e ATM. Ela é co-inventora da StemGEL e cofundadora e presidente do Conselho Consultivo Científico da Wnt Scientific.

NELSON R. PINTO 
NELSON R. PINTO
Presidente do Centro de Pesquisa em Medicina Regenerativa e Engenharia de Tecidos de Concepcion, Chile; Facultad de Odontología, Universidad de los Andes, Santiago, Chile; Visitando Professor do Departamento de Ciências da Saúde Bucal / Periodontologia; Hospitais universitários católicos University Leuven, Bélgica; Desenvolvedor de terapia de regeneração guiada natural para tecidos regeneração e cicatrização de feridas.

PAUL TRAVERS 
PAUL TRAVERS
Qualifications Date Awarding body Title of qualification 1979 Oxford University Batchelor of Arts II.1 (Biochemistry) 1983 University of London PhD Current position From (Date) Location Position October, 2007 University of Edinburgh Reader, School of Clinical Sciences Previous Posts held From (Date) Location Position 1984 Consultant Intelligenetics Corp. Palo Alto, California 1984-87 Dept of Medical Microbiology, Stanford University Medical School Research Fellow 1987-98 Dept of Crystallography, Birkbeck College, University of London Royal Society University Research Fellow 1998-2007 Anthony Nolan Research Institute Deputy Director of Research and Reader in Haematology, UCL

PHILIPPE MENASCHÉ 
PHILIPPE MENASCHÉ
Dr Philippe Menasché obtained his MD and PhD degrees from the University of Paris. He is currently Professor of Thoracic and Cardiovascular Surgery at the University of Paris Descartes, Chief of the Heart Failure Surgery Unit of the Hôpital Européen Georges Pompidou and Director of an INSERM (National Institute of Health and Medical Research) laboratory devoted to cell therapy of cardiovascular diseases. He started to work in this area more than 15 years ago and performed in 2000 the first human intramyocardial transplantation of autologous skeletal myoblasts in a patient with severe heart failure. He was then the PI of a randomised controlled trial of myoblast transplantation designed to assess the safety and efficacy of the technique. The suboptimal results of this study has then led the group to refocus on the use of cardiac progenitors derived from human embryonic stem cells (ESC). The laboratory is using small and large animal (including nonhuman primate) models of myocardial infarction and, in parallel with basic and preclinical studies on myocardial regeneration by ESC-derived cardiac progenitors, is involved in the optimisation of cell delivery and survival-enhancing techniques through the use of tissue engineering with the objective of an upcoming clinical translation in patients with end-stage heart failure who have exhausted conventional therapies.

RODRIGO MACHADO FLORENTINO
SAM M. JANES 
SAM M. JANES
I am head of respiratory medicine at University College London. I am chief investigator of the TACTICAL trial a phase 1/2 cell and gene therapy for lung cancer. I chief investigator of 4 clinical trials including the SUMMIT study screening over 12000 people for lung cancer and biomarker testing.

SHIRLEY WENKER 
SHIRLEY WENKER
Master in Biological Sciences - University of Buenos Aires (2007) and PhD in Biological Chemistry - University of Buenos Aires (2012). She completed a Post-Doctorate at Fundación Instituto Leloir- IIBBA- CONICET in the area of regenerative medicine. She is currently Research Assistant at Fundación Instituto Leloir- IIBBA CONICET, which work subject focus on cell-replacement therapy for Parkinson disease. She teaches classes at School of Sciences -University of Buenos Aires.

VITOR DE CARVALHO MORENO DAS NEVES 
VITOR DE CARVALHO MORENO DAS NEVES
NIHR Clinical Lecturer no King‘s College London e treinando para se tornar Especialista em Periodontia no Guy‘s Hospital, em Londres, Reino Unido. Graduado em Odontologia no Brasil e qualificado no Reino Unido, Vitor quer levar a odontologia adiante por meio do uso de biologia. Ele completou seu MSc em Odontologia Regenerativa e um PhD em Odontologia Translacional e Regenerativa no KCL sob a supervisão do Prof Paul Sharpe, onde criou uma técnica de autocura dentária totalmente baseada na modulação genética e ativação de células-tronco na polpa dentária. Atualmente, está tentando melhorar a prevenção da doença periodontal.


National Speakers

ANA LIZ GARCIA ALVES 
ANA LIZ GARCIA ALVES
Professor Ana Liz G. Alves DVM MSc PhD Animal Biotechnology Graduate Program Coordinator Associate Professor of Equine Surgery Regenerative Medicine Science The São Paulo State University (UNESP - Univ Estadual Paulista) Faculty of Veterinary Medicine and Animal Science Dept. of Veterinary Surgery and Animal Reproduction Graduated in Veterinary Medicine at FMVZ - USP, São Paulo, SP (1989), Residency in Large Animals Surgery (1990) at FMVZ - Unesp, Master in Medical Pathophysiology (1994) at the same institution. PhD in Medical Pathology (1998) by the Faculty of Medicine of Unesp and Free Teaching in Surgery of Large Animals after a Public Competition held in 2008 by FMVZ - Unesp. He completed a 1-year Post-Doctorate at the Royal Veterinary College-University of London (2010/2011), under the supervision of Prof. Roger K W Smith, in the area of Equine Orthopedics and Regenerative Medicine. He is currently Associate Professor III through Progression in the Unesp Teaching Career Plan, obtained in 2014 by FMVZ-Unesp. She teaches classes to students of the 3rd, 4th and 5th years of graduation in Veterinary Medicine and Graduate Studies. She is a Permanent Professor and Coordinator of the Postgraduate Program in Animal Biotechnology at FMVZ - Unesp (Capes - note 5). She is a CNPq Research Fellow, level 2 since 2006. Her current research area is Regenerative Medicine, with a focus on Veterinary Orthopedics. She is the leader of the Regenerative Therapy Research Group. She published more than 150 articles in specialized journals and numerous presentations in the annals of events. She received 8 recent research awards and / or honors. She currently coordinates 5 research projects, with international collaborations. Conducts University Extension work since 1992 in the areas of Clinic and Surgery of Large Animals (since 1992) and Regenerative Medicine (since 2005), in the form of clinical surgical assistance, veterinary consultancy, theoretical-practical courses and assistance to schools in the state of São Paulo.
AUGUSTO BARBOSA JÚNIOR 
AUGUSTO BARBOSA JÚNIOR
Biólogo, Mestre e Doutor em Fisiologia pela Faculdade de Medicina de Ribeirão Preto da Universidade de São Paulo (FMRP/USP) e realizou estágio pós-doutoral em Psicobiologia pela Faculdade de Filosofia, Ciências e Letras de Riberião Preto (FFCLRP) da USP. A mais de seis anos atua como Assessor Técnico do Departamento de Ciência e Tecnologia da Secretaria de Ciência, Tecnologia, Inovação e Insumos Estratégicos em Saúde do Ministério da Saúde (DECIT/SCTIE/MS), onde atualmente exerce o cargo de coordenador do Programa Nacional de Genômica e Saúde de Precisão, o Genomas Brasil, instituído em agosto de 2020. Biologist, Master and PhD in Physiology at the School of Medicine of Ribeirão Preto at the University of São Paulo (FMRP / USP) and did a post-doctoral internship in Psychobiology at the Faculty of Philosophy, Sciences and Letters of Riberião Preto (FFCLRP) at USP. Technical Advisor at the Department of Science and Technology of the Secretariat of Science, Technology, Innovation and Strategic Health Supplies of the Brazilian Ministry of Health (DECIT/SCTIE/MS), where he currently holds the position of Coordinator of the National Program Genomics and Precision Health, the Genomas Brasil, instituted in August 2020.
BEATRIZ MONTEIRO LONGO
BRUNO SOLANO DE FREITAS SOUZA 
BRUNO SOLANO DE FREITAS SOUZA
Possui graduação em medicina pela Universidade Federal da Bahia (2009), mestrado em Biotecnologia em Saúde e Medicina Investigativa pela Fiocruz (2012) e doutorado em Patologia Humana pela Universidade Federal da Bahia (2016). Possui MBA na área de gestão em saúde pela Fundação Getúlio Vargas (2017). Atuou como pesquisador visitante no Laboratório de Neuroimunologia do San Raffaele Scientific Institute em Milão, Itália (2010-2011). Atua como Pesquisador em Saúde Pública no Instituto Gonçalo Moniz (Fiocruz-BA) e como Médico Coordenador no Centro de Biotecnologia e Terapia Celular do Hospital São Rafael (HSR), em Salvador, onde também é o Responsável Técnico pelo Centro de Tecnologia Celular (CTC) do HSR. Desde 2018, atua como cientista colaborador do Instituto DOr de Pesquisa e Ensino (IDOR). Participa da atual gestão da Associação Brasileira de Terapia Celular, como 1o secretário. Bolsista de produtividade nível 2 do CNPq. Possui experiência em microscopia confocal, cultura de células-tronco mesenquimais, cultura de células neurais, iPSC, desenvolvimento de estudos pré-clínicos em modelos experimentais e estudos clínicos nas áreas de terapia celular e medicina regenerativa.
CARLOS EDUARDO AMBRÓSIO 
CARLOS EDUARDO AMBRÓSIO
Possui graduação pela Faculdade de Medicina Veterinária da Fundação de Ensino Octávio Bastos - São João da Boa Vista, SP (1999), mestrado em Anatomia dos Animais Domésticos pela Faculdade de Medicina Veterinária e Zootecnia - USP (2001) e doutorado em Anatomia dos Animais Domésticos e Silvestres pela Faculdade de Medicina Veterinária e Zootecnia - USP (2004). Pós-doutorado junto ao Centro de Estudos do Genoma Humano Instituto de Biociências da USP entre abril/2005 a abril/2007.Atualmente é Professor Titular em Biotecnologia da Reprodução Animal, do curso de Medicina Veterinária da Universidade de São Paulo, localizado no campus de Pirassununga, junto a FZEA (Faculdade de Zootecnia e Engenharia de Alimentos), no qual figura também como Vice Diretor desde agosto de 2018. Atualmente é coordenador adjunto da área de Medicina Veterinária, junto a CAPES. Tem experiência na área de Morfologia e Biologia da Reprodução, com ênfase nos seguintes temas: Células-tronco, estudos pré-clínicos, anatomia, morfologia, placenta e biotecnologia da reprodução. Atualmente integra grupos de pesquisa em células-tronco e terapia celular, e foi coordenador de projeto Jovem Pesquisador FAPESP com parceria com a UC/Davis - California e UNIFOR/CE. É orientador (nível mestrado e doutorado do Programa de pós-graduação em Anatomia dos Animais Domésticos e Silvestres da FMVZ/USP campus São Paulo e Biociência Animal, Campus Pirassununga. Atual presidente do Colégio Brasileiro de Reprodução Animal (2015-2019). Editor da área de Morfofisiologia da Revista Pesquisa Veterinária Brasileira desde 2009 até fevereiro de 2021, Academic Editor da Revista Plos One e Editor Chefe da Revista Animal Reproduction.
CARMEN LÚCIA KUNIYOSHI REBELATTO 
CARMEN LÚCIA KUNIYOSHI REBELATTO
Possui graduação em Ciências Biológicas pela Universidade Federal do Paraná (1990), mestrado em Genética pela Universidade Federal do Paraná (1996) e doutorado em Ciências da Saúde pela Pontifícia Universidade Católica do Paraná (2008). Atualmente é Professora adjunta da Escola de Medicina da Pontifícia Universidade Católica do Paraná, Responsável Técnica pelo Centro de Tecnologia Celular da Pontifícia Universidade Católica do Paraná e Bióloga do Hospital de Clínicas da Universidade Federal do Paraná. Tem experiência na área de Imunogenética, Genética Humana e Médica e Cultura de tecidos. Atua principalmente nos seguintes temas: histocompatibilidade, cultivo celular e células-tronco.
CÉSAR VINÍCIUS GIL BRAZ DO PRADO 
CÉSAR VINÍCIUS GIL BRAZ DO PRADO
Médico-Veterinário, com pós-graduação "latu sensu" em Acupuntura Veterinária pelo instituto Bioethicus e doutorado pela Faculdade de Medicina Veterinária e Zootecnia da Universidade de São Paulo com ênfase em terapia com células-tronco e acupuntura. Coordenador do curso de capacitação em Ozonioterapia Veterinária pela Fisioanimal. Membro da Associação Brasileira de Acupuntura Veterinária (ABRAVET), Associação Brasileira de Ozonioterapia (ABOZ) e da Associação Brasileira de Ozonioterapeutas Veterinários (ABO3VET).
DANIELA BUENO 
DANIELA BUENO
Possui graduação em Odontologia (1995), mestrado em Odontologia, Patologia Bucal, pela Faculdade de Odontologia da Universidade de São Paulo (2002); Doutorado em Genética Humana pelo Instituto de Biociências da Universidade de São Paulo (2007). Pós doutorado em Genética Humana e Células tronco no Instituto de Biociências da Universidade de São Paulo (IB-USP) e na University of California Los Angeles (UCLA), realizado de 2007 a 2011. Secretária geral da Associação Brasileira de Fissuras Lábio Palatinas (gestão 2005-2009). Pesquisadora e orientadora da pós graduação (mestrado e doutorado acadêmicos) do Instituto de Ensino e Pesquisa do Hospital Sírio-Libanês, onde desenvolve pesquisas básicas e translacionais na área de células-tronco, bioengenharia de tecidos, fissuras lábio palatinas e malformações craniofacias. É responsável técnica pelo Centro de Processamento Celular do Hospital Sírio Libanês. Investigadora principal do Projeto de bioengenharia de tecidos para portadores de malformações crânio-faciais utilizando células tronco PROADI-SUS (Ministério da saúde/ Hospital Sírio Libanês) desde 2012 até a presente data (25000.009809/2018-2020). Membro do Corpo Clinico do Hospital Municipal Infantil Menino Jesus desde 2012, onde atua como Cirurgiã Dentista, na equipe multidisciplinar de atendimento à pacientes portadores de fissuras lábio palatinas e realiza pesquisas clínicas relacionadas ao tratamento e reabilitação dos portadores de malformações craniofaciais congênitas. Foi membro do conselho multidisciplinar de saúde da ONG "Operação Sorriso Brasil" de 2012 a 2020. Em 2020 coordenou o primeiro curso online de Bioengenharia de Tecidos para o sistema musculoesquelético do Hospital Sírio-Libanês. Também em 2020 coordenou o primeiro webnar Internacional do Hospital Sírio Libanês/ Ministério da Saúde (PROADI-SUS) "Inovações do tratamento clínico à Bioengenharia de Tecidos nas malformações congênitas". Possui experiência em liderança de equipes, assistência, ensino e pesquisa.
DAVID SCHLESINGER 
DAVID SCHLESINGER
PhD in Genetics from USP Has a residency in Neurology at the HC of USP Graduated in Medicine from USP. David Schlesinger is the Chief executive officer at Mendelics Análise Genômica.
EDROALDO LUMMERTZ DA ROCHA
ERNESTO DA SILVEIRA GOULART GUIMARÃES 
ERNESTO DA SILVEIRA GOULART GUIMARÃES
Post-doctoral research fellow at the Human Genome and Stem Cell Research Center at the University of Sao Paulo. Former staff scientist at TIME (Temple University Institute for Regenerative Medicine and Engineering - USA). Entrepreneur and business developer in the biotechnology field.
FABIANO KUPCZIK 
FABIANO KUPCZIK
MD, PhD, MSc; Head of Knee Surgery of Cajuru University Hospital (PUCPR); President of SBOT-Paraná (2021); Member of Regenerative Orthopedics and Cellular Therapy Commission of SBOT; Member of Scientific Commission of SBCJ; Reviewer of RBO.
FERNANDA FERREIRA CRUZ 
FERNANDA FERREIRA CRUZ
Graduação em medicina pela Universidade Federal do Rio de Janeiro (UFRJ, 2011), Doutorado em Ciências (Fisiologia) pelo Instituto de Biofísica Carlos Chagas Filho (IBCCF), UFRJ (2013), Pós-doutorados na Universidade de Vermont, EUA, e IBCCF, UFRJ. Professora adjunta do IBCCF, UFRJ, Jovem Cientista do Nosso Estado (FAPERJ), Pesquisadora 2 do CNPq, Membro do Programa Jovens Lideranças Médicas da Academia Nacional de Medicina, Membro de Rede de Especialistas em Terapias Avançadas (RENETA).
GUILHERME BALDO 
GUILHERME BALDO
Professor at the Federal University of Rio Grande do Sul (UFRGS), working on the development of innovative treatments for rare genetic diseases, especially focused on gene therapy and genome editing. He has more than 70 articles published in international journals, with a research productivity scholarship from CNPq level 2. Professor of the Graduate Programs in Physiology and in Genetics and Molecular Biology at UFRGS, having supervised 15 master‘s and doctoral thesis (in progress or completed).
HILDA PETRS SILVA
JENIFER NOWATZKI 
JENIFER NOWATZKI
Bióloga, mestre em Biologia Celular pela UFPR e Doutora em Bioquímica Médica pela UFRJ. Adicionalmente, também tem experiência com desenvolvimento de projetos de inovação em Startups. Na ThermoFisher é especialista técnica de Biologia Celular, responsável pelos portfolios para Terapia Celular, Edição Gênica, Expressão de Proteínas Recombinantes, Cultivo Celular entre outros temas.
JOSÉ MAURO GRANJEIRO 
JOSÉ MAURO GRANJEIRO
Especialista Sênior em Metrologia e Qualidade pelo Instituto Nacional de Metrologia e Qualidade e Professor Associado da Universidade Federal Fluminense; Doutor em Ciências pela Universidade Estadual de Campinas e pós-doutorado em Biologia Celular e Molecular pelo Instituto de Química da USP; Graduado em bioquímica e biologia celular e molecular, atua nas áreas de biomateriais, biologia óssea e bioengenharia com ênfase em iocompatibilidade e toxicologia de nanomateriais.
LEONEL ALVES DE OLIVEIRA 
LEONEL ALVES DE OLIVEIRA
Graduação em Odontologia, Biólogo, Especialista em Implantodontia, Mestre em Bioquímica (UnB), Doutor em Ciências Médicas (UnB), Professor do Curso de Medicina da Universidade Federal de Brasília, Assessora Técnica do Conselho Federal de Odontologia (CFO) para assuntos relacionados a células, sangue, tecidos e órgãos com ANVISA.
LUCAS EDUARDO BOTELHO DE SOUZA 
LUCAS EDUARDO BOTELHO DE SOUZA
Holds major degrees in Teaching (2009) and Bachelor (2010) in Biological Sciences at the University of São Paulo, at the Faculty of Philosophy, Sciences and Letters of Ribeirão Preto. He holds a master‘s degree (2012) and a doctorate (2016) in Sciences from the Ribeirão Preto Medical School (USP). He completed a post-doctorate (2019) at the Institut National de la Santé et de la Recherche Médicale (INSERM U935, France) in the field of therapeutic and neoplastic stem cells. Currently, he coordinates the Gene Transfer Laboratory at the Ribeirão Preto Blood Center (FMRP / USP), where he develops basic and applied studies in gene/cell therapy, with a special focus on genetically engineered T cells.
LUIZ VICENTE RIZZO 
LUIZ VICENTE RIZZO
Médico pela Universidade de Brasília. Professor titular de imunologia na Universidade de Sao Paulo até 2009 e Professor Pleno na Faculdade Israelita de Ciências da Saúde Albert Einstein. Diretor Superintendente do Instituto Israelita de Ensino e Pesquisa Albert Einstein.
MARCIA MARTINS MARQUES 
MARCIA MARTINS MARQUES
Doutor em Patologia Oral pela FOUSP; Pós doutor em Biologia Celular no NIH, Estados Unidos. Professor Titular da FOUSP, da Universidade Ibirapuera e da Universidade Aachen, Alemanha. Presidente eleita da Assicação Brasileira de Laser na Oodntologia e Saúde (ABLOS) e membro da diretoria executiva da International Society for Laser in Dentistry ( ISLD). Sua atividade de pesquisa está focada no efeitos das terapias de fotobiomodulação e fotodinâmica antibacteriana na regeneração tecidual.
MARCO AURÉLIO KRIEGER 
MARCO AURÉLIO KRIEGER
Possui graduação em Licenciatura Plena Em Ciências Biológicas pela Universidade Federal do Paraná (1987), mestrado em Ciências Biológicas (Biofísica) pela Universidade Federal do Rio de Janeiro (1989) e doutorado em Ciências Biológicas (Biofísica) pela Universidade Federal do Rio de Janeiro (1997). Atualmente é pesquisador Titular da Fundação Oswaldo Cruz. Tem experiência na área de Genética, com ênfase em Parasitologia Molecular, atuando principalmente nos seguintes temas: Trypanosoma cruzi, expressão gênica, genômica funcional, diferenciação celular e utilização de técnicas de Biologia Molecular para o desenvolvimento de insumos para testes de diagnóstico.
MARIA ANGÉLICA MIGLINO 
MARIA ANGÉLICA MIGLINO
Maria Angélica Miglino, professora titular do Departamento de Cirurgia da FMVZ USP. Doutorou-se em 1985 pelo PPG Anatomia Funcional: Estrutura e Ultraestrutura ICB/USP. Integrou o Comitê de Área da Fapesp e do CNPq, além de ter exercido as funções de Vice-Coordenadora e Coordenadora de Área (Medicina Veterinária) da Capes. É membro da Real Academia de Ciências Veterinárias da Espanha. Sócia da Sociedade Brasileira de Anatomia, World Association of Veterinary Anatomists, e da American Society of Anatomy. Recebeu prêmios (Loke Award for Early Care Researchers, IFPA; The EPG Peter Kaufmann New Ivestigator Award; Prêmio Capes de Tese) e mais recentemente o Premio USP-Vida 2020. É pesquisadora principal do INCT (Instituto Nacional de C&T em Células-tronco e Terapia Celular no Câncer). Colaboradora do CEPID, Thecnology Transfer Project e Centro de Terapia Celular. Atua na área de Medicina Veterinária, Ciências Morfológicas, Biologia do Desenvolvimento com ênfase à Placenta e Placentação, Terapia Celular em Modelos Animais, e Engenharia Tecidual, desenvolvendo projetos tecnológicos multidisciplinares voltados à regeneração de órgãos e de tecidos.
MARIANA OLIVEIRA 
MARIANA OLIVEIRA
Mariana Oliveira é bióloga formada pela Universidade Estadual de Campinas (Unicamp), mestre em ciências pelo departamento de Morfologia e Genética da Universidade Federal de São Paulo (Unifesp), grande entusiasta da ciência e das novas terapias, atua no mercado de ciências da vida há mais de 10 anos e no mercado de terapia celular há 6 anos. Atualmente é especialista de produtos e responsável técnica na área de Terapia Celular e Gênica na América Latina na empresa Cytiva.
MARTIN HERNAN BONAMINO 
MARTIN HERNAN BONAMINO
Possui graduação em Ciências Biológicas Modalidade Medica pela Universidade Federal do Rio de Janeiro (2000) e doutorado em Química Biológica pela Universidade Federal do Rio de Janeiro (2004). Atualmente é pesquisador do Instituto Nacional de Câncer e Especialista da Fundação Instituto Oswaldo Cruz, onde participa da coordenação da Rede FioCâncer. É bolsista Cientista do Nosso Estado (CNE) da FAPERJ, membro da câmara técnica de trabalho da ANVISA para terapias avançadas e do Global Outreach committee da American Society of Gene & Cell Therapy. www.martinlab.net.
MILTON A RUIZ 
MILTON A RUIZ
Coordinator Department Bone Marrow Transplant, Associação Portuguesa de Beneficência, SJ Rio Preto, SP. Brazil Past VP South and Central America International Society for Cellular Therapy (ISCT). Former Professor Hematology FM USP, SP. Brazil Former Editor Revista Brasileira de Hematologia e Hemoterapia.
MONICA DIUANA CALASANS MAIA 
MONICA DIUANA CALASANS MAIA
Graduação em Odontologia, Especialista e Mestre em Cirurgia Bucomaxilofacial pela Universidade Federal do Rio de Janeiro; Doutor em Patologia Oral pela Universidade Federal Fluminense; Professora do PPGOdontologia UFF; Membro da Rede de Bioengenharia do Estado do Rio de Janeiro; Membro da Rede NanoSaude, Bolsista Faperj.
PATRICIA FURTADO MALARD 
PATRICIA FURTADO MALARD
Formada em Medicina Veterinária pela UFMG (1997). Possui mestrado em Medicina Veterinária pela Universidade Federal de Minas Gerais (2000). Atuou como professora nas Faculdades Integradas do Planalto Central e nas Faculdades da Terra de Brasília. Atualmente é professora de Pós Graduação do Instituto Qualittas e Doutoranda do Curso de Pós graduação em Biotecnologia da Universidade Católica de Brasília. Sócia-proprietária dos laboratórios BIO Biotecnologia em Reprodução Animal e BIO CELL Terapia Celular, onde exerce cargo de gestão. Tem experiência na área de Biotecnologia e Terapia Celular com células-tronco.
PATRICIA HELENA LUCAS PRANKE
PATRICIA RIEKEN MACEDO ROCCO 
PATRICIA RIEKEN MACEDO ROCCO
Patricia Rocco, MD, PhD, Vice-Presidente do ISCT para as regiões da América do Sul e Central, Professora Titular da Universidade Federal do Rio de Janeiro, onde dirige o Laboratório de Investigação Pulmonar. Membro Eleito da Academia Nacional de Medicina do Brasil e da Academia Brasileira de Ciências. É autora e co-autora de mais de 360 ​​publicações revisadas por pares e 120 capítulos de livros.
PEDRO MORENO PIMENTEL COELHO 
PEDRO MORENO PIMENTEL COELHO
É Professor Adjunto do Instituto de Biofísica Carlos Chagas Filho da UFRJ. Atua como pesquisador associado do Laboratório de Neurobiologia Comparativa e do Desenvolvimento (https://pesquisa.biof.ufrj.br/neurobiologia/lnbcd/), onde coordena o Grupo de Pesquisa em Neuropatologia Experimental (dgp.cnpq.br/dgp/espelhogrupo/1022226587675588). Está credenciado como orientador pelo Programa de Pós-Graduação em Ciências Biológicas (Fisiologia) da UFRJ, desenvolvendo estudos pré-clínicos e pesquisas sobre a fisiopatologia de doenças neurológicas como a encefalopatia neonatal e o acidente vascular encefálico hemorrágico. Atua como representante dos Professores Adjuntos do Centro de Ciências da Saúde no Conselho Universitário (CONSUNI) da UFRJ. É médico pela UFRJ (2007; Cum Laude) e possui doutorado pelo Programa de Pós-Graduação em Ciências Morfológicas do Instituto de Ciências Biomédicas da UFRJ (2010). Realizou estágio de doutorado sanduíche (2009) e pós-doutorado no grupo de pesquisa do Dr. Serge Rivest na Université Laval (Québec, Canadá; 2010-2013). Atuou como 2º Secretário da Associação Brasileira de Terapia Celular (ABTCel; 2017-2019), como coordenador adjunto (substituto eventual) do Programa de Medicina Regenerativa (12/2017-01/2020) e como membro da Coordenação de Atividades Científicas (CAC) do Instituto de Biofísica Carlos Chagas Filho da UFRJ (2018-2020). Participa de atividades de extensão no Espaço Alexandria da UFRJ. É Jovem Cientista do Nosso Estado (FAPERJ), bolsista de produtividade do CNPq (nível 2, edital 2020) e membro do Programa Jovens Lideranças Médicas da Academia Nacional de Medicina.
RAFAEL LINDEN 
RAFAEL LINDEN
Graduado em Medicina (1975) e Doutor em Ciências Biológicas (Biofísica, 1979), ambos pela UFRJ, fez pós-doutorado na Universidade de Oxford (1980-1982). Atualmente é Professor Titular da UFRJ (desde 1994) e Chefe do Laboratório de Neurogênese (desde 1985). Pioneiro, no Brasil, na pesquisa básica em neurodegeneração e neuroproteção, criou e coordenou o projeto do Instituto do Milênio de Terapia Gênica (2005-2008), e é membro da Rede Nacional de Especialistas em Terapias Avançadas (Reneta) da ANVISA. É Pesquisador 1A do CNPq, Cientista do Nosso Estado da FAPERJ, membro titular da Academia Brasileira de Ciências, da Academia de Medicina do Rio de Janeiro, da Academia de Ciências da América Latina e da TWAS. Recebeu da Sociedade Brasileira de Neurociências e Comportamento (SBNeC) o Prêmio Cesar Timo-Iaria pelo conjunto de suas contribuições às Neurociências e foi condecorado pela Presidência da República com a Comenda (2001) e a Grã-Cruz (2007) da Ordem Nacional do Mérito Científico.
RENATA MIRANDA PARCA 
RENATA MIRANDA PARCA
Possui graduação em Ciências Biológicas pela Universidade de Brasília (2003) e mestrado em Biologia Animal pela Universidade de Brasília (2006). Atualmente é Especialista em Regulação e Vigilância Sanitária da Agência Nacional de Vigilância Sanitária. Tem experiência na área de Fisiologia, histologia e microscopia atuando principalmente nos seguintes temas: nanotecnologia, transplante de órgãos e tecidos, reprodução humana assistida e células-tronco (com ênfase na regulação sanitária destes serviços).
RENATO ABDALA KARAM KALIL 
RENATO ABDALA KARAM KALIL
Graduado em Medicina pela Universidade Federal do Rio Grande do Sul (1970), Mestrado (1980) e Doutorado (1987) em Medicina: Cardiologia, pela Universidade Federal do RS. Professor Titular do Departamento de Clínica Cirúrgica da UFCSPA (Universidade Federal de Ciências da Saúde de Porto Alegre). Coordenador do Núcleo de Cardiopatias Congênitas do Hospital Moinhos de Vento, como Chefe da Cardiologia e Cirurgia Cardíaca Pediátricas. É Cirurgião Cardiovascular, Pesquisador e Professor Emérito do Programa de Pós-Graduação em Cardiologia, do Instituto de Cardiologia do RS - Fundação Universitária de Cardiologia (IC-FUC), Instituição onde foi Coordenador do Programa de Pós-Graduação (Mestrado e Doutorado) de 1999 a 2002, Diretor Científico de 2002 a 2011 e Coordenador do Programa de Pós-Graduação Mestrado Profissional em Processos de Pesquisa e Inovação em Saúde de 2013 a 2017; No IC-FUC, criou entre outras iniciativas, o Laboratório de Cardiologia Molecular e Celular, o Centro de Pesquisa Clínica (CEPEC-FUC) e o Centro de Telemedicina. Preside a Cooperativa dos Cirurgiões Cardiovasculares do Rio Grande do Sul desde agosto 2012; Diretor de Comunicação (Gestão 2008-2009) e Diretor de Pesquisa (2010-2011) da Sociedade Brasileira de Cardiologia - SBC; Diretor Científico da Sociedade Brasileira de Cirurgia Cardiovascular (2016-2020); Pesquisador PQ2 do Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq). Membro Titular do Comitê de Assessoramento da Área de Medicina (CA-MD) CNPq (2005-2010). Coordenou a Rede Gaúcha de Terapia Celular (2010-2014), com apoio FAPERGS/CNPq/PRONEX. É membro das seguintes Sociedades Científicas: Sociedade Gaúcha de Cirurgia Cardiovascular, Sociedade Brasileira de Cirurgia Cardiovascular, The Society of Thoracic Surgeons (USA), Sociedade de Cardiologia do RGS, Sociedade Brasileira de Cardiologia - SBC, American Heart Association, American College of Cardiology e American Association for the Advancement os Science. Membro do Conselho Editorial da Revista Brasileira de Cirurgia Cardiovascular / Brazilian Journal of Cardiovascular Surgery e dos Arquivos Brasileiros de Cardiologia - SBC. Tem experiência na área de Cardiologia, atuando em Cirurgia Cardiovascular de Adultos e Cirurgia Cardíaca Pediátrica. Linhas de pesquisa principais: Fibrilação Atrial, Cirurgia Cardiovascular e Biologia Molecular Aplicada à Cardiologia.
RENATO LUIZ GUERINO CUNHA 
RENATO LUIZ GUERINO CUNHA
Possui graduação em Medicina pela Faculdade de Medicina da Universidade Federal de Uberlândia (2004), especialização em Clínica Médica pelo Hospital das Clínicas Faculdade de Medicina da Universidade Federal de Uberlândia (2007), em Hematologia e Hemoterapia (2009) e Transplante de Medula Óssea e Terapia Celular (2010) pelo Hospital das Clínicas da Faculdade de Medicina de Ribeirão Preto da Universidade de São Paulo (HC-FMRP-USP). Doutor em Clinica Médica pela Faculdade de Medicina de Ribeirão Preto da Universidade de São Paulo e doutor em Terapia Celular e Biotecnologia pela Universidade de Paris-Diderot (Paris VII, Paris-França, 2014). Pós-doutorado em Transplante de Medula Óssea e Terapia Celular pelo National Cancer Institute (ETIB-NCI/NHI) em Bethesda, EUA (2015-2018). Desde 2019 é Professor Doutor da Faculdade de Medicina de Ribeirão Preto da Universidade de São Paulo (FMRP-USP) e Coordenador da Unidade de Transplante de Medula Óssea e Terapia Celular do HC-FMRP-USP. Membro da Sociedade Brasileira de Transplante de Medula Óssea (2009), Associação Brasileira de Hematologia e Hemoterapi (2009), American College Physician (2015), American Society of Hematology (2016) e American Society for Transplantation and Cellular Therapy (2020). Em 2018 recebeu o prêmio ASH Global Research Award e, em 2019 realizou o primeiro tratamento com células CAR T da América Latina, em Ribeirão Preto-Brasil.
RICARDO DE SOUZA TESCH 
RICARDO DE SOUZA TESCH
Graduação em Odontologia pela Universidade Federal do Rio de Janeiro; Especialização em Ortodontia, Associação dos Cirurgiões Dentistas de Campinas; Mestre em Medicina com concentração em Cirurgia de Cabeça e Pescoço pelo Hospital Heliópolis e Doutor em Clínica Médica (Neurologia) pela Universidade Federal do Rio de Janeiro; Professor da Faculdade de Medicina de Petrópolis e Coordenador do Curso de Especialização em DTM e Dor Orofacial; Pesquisador com especial interesse nas áreas de DTM e Dor Orofacial, Dores de Cabeça, Genética e Medicina Regenerativa, esta última com ênfase no uso de Terapias Celulares para Regeneração de Cartilagem e Óssea; Pesquisador principal do primeiro ensaio clínico humano para regeneração da ATM usando transplante autólogo de condrócitos de septo nasal.
ROBERTO GIUGLIANI 
ROBERTO GIUGLIANI
Dr. Roberto Giugliani, MD, PhD, is a medical geneticist with specialization in inherited metabolic diseases. He is Full Professor at the Department of Genetics of the Federal University of Rio Grande do Sul, being the founder and active member of the Medical Genetics Service of the University Hospital, in Porto Alegre, Brazil. He is also Editor-in-Chief of the Journal of Inborn Errors of Metabolism and Screening, Chairman of the Latin American School of Human and Medical Genetics (ELAG), and Member of Brazilian Academy of Sciences. He is past President of the Latin American Society of Inborn Errors of Metabolism and Newborn Screening (SLEIMPN), the Latin American Network of Human Genetics (RELAGH), and the Brazilian Society of Medical Genetics and Genomics (SBGM). Prof. Giugliani’s main interests are concentrated in screening, diagnosis, and treatment of inborn errors of metabolism, particularly of lysosomal storage diseases, having supervised the training of over 100 MSc and PhDs, and being author of more than 480 scientific papers.
ROSALIA MENDEZ-OTERO 
ROSALIA MENDEZ-OTERO
Medical degree from Federal University of Rio de Janeiro (1977), Master (1980) and PhD (1985) in Biological Sciences from Federal University of Rio de Janeiro. Postdoctoral fellow at Yale University (1985-1987). Faculty member at Federal University of Rio de Janeiro since 1980. Vice-Director of the Carlos Chagas Filho Institute of Biophysics / UFRJ. Founding member and President of the Brazilian Association of Cellular and Gene Therapy (ABTCel). Titular member of the Brazilian Academy of Sciences (ABC) since 2006. National Order of Scientific Merit (2006). Currently Full professor at Federal University of Rio de Janeiro and Head of the Laboratory of Cellular and Molecular Neurobiology. Experience in the area of ​​Neuroscience and Neurology working in basic, pre-clinical and clinical research with cell and gene therapies.
SANG WON HAN 
SANG WON HAN
Possui graduação em Química, mestrado e doutorado em Bioquímica pela Universidade de São Paulo, pós-doutorado em Terapia Gênica pela University of Washington e livre-docência em Biofísica pela Universidade Federal de São Paulo. Foi professor de Bioquímica na Unesp-Rio Claro entre 1988-1996, e desde 1996 é professor de Biofísica na Escola Paulista de Medicina da Unifesp. Atualmente, é professor titular e ativo do departamento de biofisica da Unifesp. Foi co-fundador do Centro Interdisciplinar de Terapia Gênica (CINTERGEN) na Unifesp, e foi diretor desde sua fundação em 2004 até 2010 (o nome atual de CINTERGEN é CTCMol). É membro da Câmara técnica de Terapias avançadas da ANVISA e representante de especialistas da RENETA-ANVISA. Desde 2019 é vice-presidente da Associação brasileira de terapia celular e gênica. As principais linhas de pesquisas são: terapia gênica de doenças isquêmicas e genéticas, de câncer e vacina de DNA.
URSULA MATTE
invited
speakers

ANA LIZ GARCIA ALVES
Professor Ana Liz G. Alves DVM MSc PhD Animal Biotechnology Graduate Program Coordinator Associate Professor of Equine Surgery Regenerative Medicine Science The São Paulo State University (UNESP - Univ Estadual Paulista) Faculty of Veterinary Medicine and Animal Science Dept. of Veterinary Surgery and Animal Reproduction Graduated in Veterinary Medicine at FMVZ - USP, São Paulo, SP (1989), Residency in Large Animals Surgery (1990) at FMVZ - Unesp, Master in Medical Pathophysiology (1994) at the same institution. PhD in Medical Pathology (1998) by the Faculty of Medicine of Unesp and Free Teaching in Surgery of Large Animals after a Public Competition held in 2008 by FMVZ - Unesp. He completed a 1-year Post-Doctorate at the Royal Veterinary College-University of London (2010/2011), under the supervision of Prof. Roger K W Smith, in the area of Equine Orthopedics and Regenerative Medicine. He is currently Associate Professor III through Progression in the Unesp Teaching Career Plan, obtained in 2014 by FMVZ-Unesp. She teaches classes to students of the 3rd, 4th and 5th years of graduation in Veterinary Medicine and Graduate Studies. She is a Permanent Professor and Coordinator of the Postgraduate Program in Animal Biotechnology at FMVZ - Unesp (Capes - note 5). She is a CNPq Research Fellow, level 2 since 2006. Her current research area is Regenerative Medicine, with a focus on Veterinary Orthopedics. She is the leader of the Regenerative Therapy Research Group. She published more than 150 articles in specialized journals and numerous presentations in the annals of events. She received 8 recent research awards and / or honors. She currently coordinates 5 research projects, with international collaborations. Conducts University Extension work since 1992 in the areas of Clinic and Surgery of Large Animals (since 1992) and Regenerative Medicine (since 2005), in the form of clinical surgical assistance, veterinary consultancy, theoretical-practical courses and assistance to schools in the state of São Paulo.
Ashley Umlauf
Ashley Umlauf is a Cell Culture and Cell Therapy Field Applications Scientist II (FAS) with ThermoFisher Scientific. Ashley leverages her significant experience in designing and developing numerous commercialized medical devices to act as a primary technical consultant for her cell and gene therapy customers. Ashley holds a B.S. degree in Biochemistry and Molecular Biology from the University of Wisconsin.
AUGUSTO BARBOSA JÚNIOR
Biologist, Master and PhD in Physiology at the Ribeirão Preto School of Medicine at the University of São Paulo (FMRP / USP) and did a post-doctoral internship in Psychobiology at the Faculty of Philosophy, Sciences and Letters of Riberião Preto (FFCLRP) at USP. For more than six years, he has served as Technical Advisor to the Department of Science and Technology of the Department of Science, Technology, Innovation and Strategic Health Supplies of the Ministry of Health (DECIT / SCTIE / MS), where he currently holds the position of coordinator of the National Program Genomics and Precision Health, Genomas Brasil, instituted in August 2020. Biologist, Master and PhD in Physiology at the School of Medicine of Ribeirão Preto at the University of São Paulo (FMRP / USP) and did a post-doctoral internship in Psychobiology at the Faculty of Philosophy, Sciences and Letters of Riberião Preto (FFCLRP) at USP. Technical Advisor at the Department of Science and Technology of the Secretariat of Science, Technology, Innovation and Strategic Health Supplies of the Brazilian Ministry of Health (DECIT / SCTIE / MS), where he currently holds the position of Coordinator of the National Program Genomics and Precision Health, the Genomas Brasil, instituted in August 2020.
BENJAMIN P. KLEINSTIVER
ASSISTANT PROFESSOR OF PATHOLOGY, MASSACHUSETTS GENERAL HOSPITAL AND HARVARD MEDICAL SCHOOL.
BRUCE LEVINE
Barbara and Edward Netter Professor in Cancer Gene Therapy University of Pennsylvania Perelman School of Medicine. Specialty Division: Transfusion Medicine & Therapeutic Pathology Research Expertise: Immunology, Cell and Gene Therapy Other Expertise: Good Manufacturing Practices Itmat Expertise: Dr. Levine‘s interests include cell, gene, and biologic therapy clinical trial development, manufacturing, and testing and lymphocyte growth, activation and senescence. Education: B.A. (Major-Biology, Minor-History), The University of Pennsylvania , 1984 Ph.D. (Immunology and Infectious Diseases), The Johns Hopkins University, 1992 Specialty Certification: Postgraduate Training Post-doctoral Fellow, Henry M. Jackson Foundation, Naval Medical Research Institute, National Naval Medical Center, Bethesda, MD, 1992-1996.
BRUNO SOLANO DE FREITAS SOUZA
Graduated in medicine from the Federal University of Bahia (2009), master‘s degree in Biotechnology in Health and Investigative Medicine from Fiocruz (2012) and doctorate in Human Pathology from the Federal University of Bahia (2016). He has an MBA in health management from Fundação Getúlio Vargas (2017). He worked as a visiting researcher at the Neuroimmunology Laboratory at the San Raffaele Scientific Institute in Milan, Italy (2010-2011). He works as a Researcher in Public Health at the Gonçalo Moniz Institute (Fiocruz-BA) and as a Coordinating Physician at the Center for Biotechnology and Cell Therapy at the São Rafael Hospital (HSR), in Salvador, where he is also the Technical Responsible for the Cell Technology Center (CTC) ) of the HSR. Since 2018, he has worked as a collaborating scientist at the DOr Institute for Research and Education (IDOR). Participates in the current management of the Brazilian Association of Cell Therapy, as 1st secretary. CNPq level 2 productivity scholarship. He has experience in confocal microscopy, culture of mesenchymal stem cells, culture of neural cells, iPSC, development of preclinical studies in experimental models and clinical studies in the areas of cell therapy and regenerative medicine.
CARLOS EDUARDO AMBRÓSIO
Graduated from the Faculty of Veterinary Medicine of the Fundação de Ensino Octávio Bastos - São João da Boa Vista, SP (1999), master‘s degree in Anatomy of Domestic Animals from the Faculty of Veterinary Medicine and Animal Science - USP (2001) and doctorate in Anatomy of Domestic Animals and Silvestres by the Faculty of Veterinary Medicine and Zootechnics - USP (2004). Postdoctoral fellow at the Human Genome Studies Center Institute of Biosciences at USP between April / 2005 to April / 2007. He is currently Full Professor in Biotechnology of Animal Reproduction, of the Veterinary Medicine course at the University of São Paulo, located on the campus of Pirassununga, with FZEA (Faculty of Zootechnics and Food Engineering), in which he also appears as Vice Director since August 2018. He is currently assistant coordinator of the Veterinary Medicine area, with CAPES. He has experience in the area of ​​Morphology and Biology of Reproduction, with emphasis on the following themes: stem cells, pre-clinical studies, anatomy, morphology, placenta and biotechnology of reproduction. He is currently a member of research groups on stem cells and cell therapy, and was coordinator of the Young Researcher FAPESP project in partnership with UC / Davis - California and UNIFOR / CE. He is an advisor (master‘s and doctoral level of the post-graduate program in Anatomy of Domestic and Wild Animals at the FMVZ / USP campus São Paulo and Animal Bioscience, Campus Pirassununga. Current president of the Brazilian College of Animal Reproduction (2015-2019). Morphophysiology area of ​​Revista Pesquisa Veterinária Brasileira from 2009 to February 2021, Academic Editor of Revista Plos One and Chief Editor of Revista Animal Reproduction.
CARLOS JAVIER ALMECIGA DÍAZ
Bachelor on Pharmacy from Universidad Nacional de Colombia, and Doctor of Biological Sciences from Pontificia Universidad Javeriana. Associate Professor and Director of the Institute for the Study of Inborn Errors of Metabolism at Pontificia Universidad Javeriana. I have worked in gene therapy for Morquio A using AAV and lentiviral vectors, and currently I‘m exploring the use of CRISPR/Cas9 as gene therapy tool for several inborn errors of metabolism. I have also worked in the production and characterization of recombinant five lysosomal enzymes in microorganisms (bacteria and yeast) for the development of novel ERTs. I also worked in the application of bioinformatics tools for the study of the inborn errors of the metabolism, such as protein modeling, mutation effect, docking, and systems biology.
CARMEN LÚCIA KUNIYOSHI REBELATTO
Graduated in Biological Sciences from the Federal University of Paraná (1990), master‘s degree in Genetics from the Federal University of Paraná (1996) and doctorate in Health Sciences from the Pontifical Catholic University of Paraná (2008). She is currently Assistant Professor at the Medical School of the Pontifical Catholic University of Paraná, Technical Responsible for the Center for Cellular Technology at the Pontifical Catholic University of Paraná and Biologist at the Hospital de Clínicas of the Federal University of Paraná. Has experience in Immunogenetics, Human and Medical Genetics and Tissue Culture. She mainly works on the following themes: histocompatibility, cell culture and stem cells.
CÉSAR VINÍCIUS GIL BRAZ DO PRADO
Veterinarian, with post-graduation "latu sensu" in Veterinary Acupuncture by the Bioethicus institute and doctorate by the Faculty of Veterinary Medicine and Zootechnics at the University of São Paulo with an emphasis on stem cell therapy and acupuncture. Coordinator of the training course in Veterinary Ozone Therapy by Fisioanimal. Member of the Brazilian Association of Veterinary Acupuncture (ABRAVET), Brazilian Association of Ozone Therapy (ABOZ) and of the Brazilian Association of Veterinary Ozone Therapists (ABO3VET).
CHARLES E. MURRY
Dr. Charles Murry received his bachelor’s degree in chemistry from the University of North Dakota, followed by MD-PhD training at Duke University, where he studied myocardial ischemia-reperfusion injury. He did residency training in Pathology at the University of Washington, followed by fellowship training in vascular biology and diagnostic cardiovascular pathology. He is currently a professor in the departments of Laboratory Medicine & Pathology, Bioengineering, and Medicine/Cardiology at the University of Washington. Murry’s research focuses on stem cell biology, with an emphasis on understanding differentiation of the human cardiovascular system and using these cells to study diseases and to regenerate damaged tissues. His group is a world leader in heart regeneration and is working toward a clinical trial using cardiomyocyte therapy. In addition to running his research group, Dr. Murry is the director of the UW Institute for Stem Cell and Regenerative Medicine. He has served on many local, national and international committees, spoken widely about stem cells and cardiovascular medicine, and he has received numerous awards for teaching and scientific achievement. Dr. Murry is a member of the ISSCR Board of Directors and the ISSCR Clinical Translation Committee. Most recently, Murry moved part of his research group to Sana Biotechnology, where he now serves as Senior VP and Chief Scientific Officer for Cell Therapy. His team at Sana is working to bring stem cellbased heart regeneration into clinical trials.
CLAUDIA DOS SANTOS
Dr. dos Santos is a Scientist in the Keenan Research Center of the Li Ka Shing Knowledge Institute of St. Michael‘s Hospital and an Assistant Professor of Medicine, Department of Medicine, Division of Respirology and Interdepartmental Division of Critical Care at the University of Toronto. She did her BSc Hons in Biology at Trent University, her MSc degree at the Hospital for Sick Children in Molecular and Medical Genetics where she worked with Dr. Manuel Buchwald on Fanconi’s Anemia and DNA repair and her Medical degree, Internal Medicine and Critical Care training at the University of Toronto. She continued in Toronto for her post-doc in the lab of Dr. Arthur Slutsky, a world renowned expert on mechanical ventilation and Dr. Mingyao Liu an expert on mechanotransduction. Dr. dos Santos now holds an appointment at the Institute of Medical Sciences and Collaborative Program in Genome Biology and Bioinformatics. Her clinical specialty is Critical Care Medicine. She held a Fellowship from the Parker B. Francis Foundation, a Phase I Clinician-Scientist from the Heart and Stroke Foundation, and now holds an Early Research Award from the Ministry of Research and Innovation and a New Investigator Award from the Canadian Institutes of Health Research (CIHR).
CLAUDIO SPERA
Trained Ophthalmologist, over 20 years in strategic Medical Affairs and recognised experience in launching and network building in gene therapy. Leading ocular gene at Novartis with strategic global medical leadership in the ocular gene portfolio. Close collaboration with key cross-functional stakeholders on the Ocular Gene therapies pipeline to shape the access and outcomes for patients with inherited retinal diseases and other blinding diseases, leveraging recognized experience in launching and network building in Gene Therapy.
DANIEL J. WEISS
Professor of Medicine at University of Vermont College of Medicine. I have had a longstanding interest in lung repair and regeneration after injury, notably gene and cell therapy approaches for lung diseases. In particular this has included developing novel techniques with which to investigate and enhance lung gene and cell therapies. Recent published work in cell therapy approaches for lung diseases has included several benchmark publications that have included the first ever trial of cell therapy for COPD and that have helped define whether exogenous cells can engraft in the lung. As such, I view myself as a translational scientist whose work spans from benchtop to clinical trials. I have also instituted a biennial meeting held at the University of Vermont, Stem Cells and Cell Therapies in Lung Biology and Diseases, that is widely viewed by the NIH, FDA, and non-profit Respiratory Disease Foundations as the major meeting in the field. My overall goal is to provide a firm scientific basis for clinical application of cell therapies in lung diseases. I have been funded by the NIH, DOD, non-profit Respiratory Disease Foundations, and by industry sources since 1995. Current work in the laboratory is focused in three major areas: 1) Bioengineering approaches for development of functional lung tissue; 2) Immunomodulation of lung inflammation by mesenchymal stromal cells (MSCs); 3) Development of cell therapy-based approaches for lung disease.
DANIELA BUENO
Graduated in Dentistry (1995), Master in Dentistry, Oral Pathology, by the Faculty of Dentistry, University of São Paulo (2002); PhD in Human Genetics by the Institute of Biosciences, University of São Paulo (2007). Post-doctorate in Human Genetics and Stem Cells at the Institute of Biosciences of the University of São Paulo (IB-USP) and at the University of California Los Angeles (UCLA), held from 2007 to 2011. General secretary of the Brazilian Association of Cleft Palates (management) 2005-2009). Postgraduate researcher and advisor (academic master‘s and doctorate) at the Teaching and Research Institute of Hospital Sírio-Libanês, where she develops basic and translational research in the area of ​​stem cells, tissue bioengineering, cleft lip and craniofacial malformations. She is technically responsible for the Cell Processing Center of Hospital Sírio Libanês. Principal investigator of the Tissue Bioengineering Project for patients with craniofacial malformations using stem cells PROADI-SUS (Ministry of Health / Hospital Sírio Libanês) from 2012 to the present date (25000.009809 / 2018-2020). Member of the Clinical Body of the Municipal Hospital Infantil Menino Jesus since 2012, where she works as a Dental Surgeon, in the multidisciplinary team of care for patients with cleft lip and palate and conducts clinical research related to the treatment and rehabilitation of patients with congenital craniofacial malformations. She was a member of the multidisciplinary health council of the NGO "Operation Smile Brazil" from 2012 to 2020. In 2020 he coordinated the first online course on Bioengineering Tissues for the musculoskeletal system of Hospital Sírio-Libanês. Also in 2020, he coordinated the first International webnar at the Hospital Sírio Libanês / Ministry of Health (PROADI-SUS) "Innovations in the clinical treatment of tissue bioengineering in congenital malformations". She has experience in team leadership, assistance, teaching and research.
DAVID COURTMAN
Senior Investigator, Regenerative Medicine Program - Ottawa Hospital Research Institute. Director, Cell Manufacturing, Biotherapeutics Core Facilities - Ottawa Hospital Research Institute. Assistant Professor, Dept of Medicine, Faculty of Medicine - University of Ottawa. Dr. Courtman has developed and assessed, both biologically and biomechanically, novel tissue, protein, and cell based biomaterials for use in vascular grafts and heart valves. He has made fundamental contributions to field of vascular pathobiology furthering our understanding of disease progression and tissue material interactions. More recently he has been instrumental in the development of a number of cellular based gene therapies for the treatment of cardio-pulmonary disorders taking them from initial concept, through appropriate animal disease models, and into first in man clinical trials. He is currently directing the manufacturing of these cell products for trials treating patients suffering from pulmonary arterial hypertension, myocardial infarction, and sepsis.
DONG-SEOK SOHN
Chairman and Professor, Department of Dentistry and Oral and Maxillofacial Surgery, School of Medicine, Catholic University of Deagu, Republic of Korea. President and founding of World Academy of Ultrasonic Piezoelectric Bone Surgery (www.waups.org); Past President of ICOI Asia-pacific section and founding President of ICOI Korea (Korean Society of Oral Implantologists); Chair of 9th Congress of ICOI Asia Pacific Section and Co-congress chair of 28th ICOI World Congress and World Congress of Ultrasonic Piezoelectric Bone Surgery; Creator and disseminator of many techniques in regenerative medicine such as stick bone and dental graft.
FABIANA ARZUAGA
Ministry of Science, Technology and Productive Innovation Argentina · Advisory Commission in Regenerative Medicine and Cellular Therapies.
FERNANDA FERREIRA CRUZ
Graduated in medicine at the Federal University of Rio de Janeiro (UFRJ, 2011), PhD in Sciences (Physiology) by the Biophysics Institute Carlos Chagas Filho (IBCCF), UFRJ (2013), Post-doctorates at the University of Vermont, USA, and IBCCF , UFRJ. Adjunct Professor at IBCCF, UFRJ, Young Scientist of Our State (FAPERJ), Researcher 2 at CNPq, Member of the Young Medical Leadership Program at the National Academy of Medicine, Member of the Network of Specialists in Advanced Therapies (RENETA).
GUILHERME BALDO
Professor at the Federal University of Rio Grande do Sul (UFRGS), working on the development of innovative treatments for rare genetic diseases, especially focused on gene therapy and genome editing. He has more than 70 articles published in international journals, with a research productivity scholarship from CNPq level 2. Professor of the Graduate Programs in Physiology and in Genetics and Molecular Biology at UFRGS, having supervised 15 master‘s and doctoral thesis (in progress or completed).
GUILLERMO GRANDE
Former Professor of Clinical Equine FCV-UNL Actual Adscripto Graduate of Hospital Practice FCV-UNL.
HUGO PELUFFO
Associate (Tenure) Professor Department of Histology and Embryology Faculty of Medicine Universidad de la República and Principal Investigator Neuroinflammation and Gene Therapy Laboratory Institut Pasteur Montevideo Uuruguay. Publications: https://pubmed.ncbi.nlm.nih.gov/?term=peluffo%2C+h&sort=date
JACQUES EDUARDO NÖR
Chair, Dept. Cariology, Restorative Sciences, Endodontics, University of Michigan School of Dentistry; Professor of Otolaryngology, University of Michigan School of Medicine; Professor of Biomedical Engineering, University of Michigan College of Engineering; Professor of Dentistry, University of Michigan School of Dentistry; President-Elect, American Association for Dental Research (AADR); Associate Editor, Journal of Dental Research; Member: 29 Editorial boards.
JENIFER NOWATZKI
Biologist, Master in Cell Biology at UFPR and PhD in Medical Biochemistry at UFRJ. Additionally, she also has experience with developing innovation projects in Startups. At ThermoFisher, she is a technical specialist in Cell Biology, responsible for the portfolios for Cell Therapy, Gene Editing, Expression of Recombinant Proteins, Cell Culture among other topics.
JOSÉ MAURO GRANJEIRO
Senior Specialist in Metrology and Quality at the National Institute of Metrology and Quality and Associate Professor at Universidade Federal Fluminense; PhD in Sciences by the Universidade Estadual de Campinas and post-doctorate in Cellular and Molecular Biology at the Institute of Chemistry at USP; Degree in biochemistry and cellular and molecular biology, works in the areas of biomaterials, bone biology and bioengineering with an emphasis on iocompatibility and toxicology of nanomaterials.
LEONEL ALVES DE OLIVEIRA
Graduation in Dentistry, Biologist, Specialist in Implantology, Master in Biochemistry (UNB), Doctor in Medical Sciences (UNB), Professor in the Medicine course at Universidade Federal de Brasília, Technical advisor to the Conselho Federal de Odontologia (CFO) for matters related to cells, blood, tissues and organs with ANVISA.
LESLEY FORRESTER
PhD at University of Edinburgh on the clonality of the haematopoietic stem cell system. EMBO Postdoctoral fellowship in Toronto, Samuel Lunenfeld research institute with Alan Bernstein. – Here I got interested in generating blood from embryonic stem cells (4 years from 1989-1993). MRC Senior Fellowship to set up my own lab in Edinburgh where I have been ever since.
LUCAS EDUARDO BOTELHO DE SOUZA
Holds major degrees in Teaching (2009) and Bachelor (2010) in Biological Sciences at the University of São Paulo, at the Faculty of Philosophy, Sciences and Letters of Ribeirão Preto. He holds a master‘s degree (2012) and a doctorate (2016) in Sciences from the Ribeirão Preto Medical School (USP). He completed a post-doctorate (2019) at the Institut National de la Santé et de la Recherche Médicale (INSERM U935, France) in the field of therapeutic and neoplastic stem cells. Currently, he coordinates the Gene Transfer Laboratory at the Ribeirão Preto Blood Center (FMRP / USP), where he develops basic and applied studies in gene/cell therapy, with a special focus on genetically engineered T cells.
LUIZ VICENTE RIZZO
Physician from the University of Brasilia. Full professor of immunology at the University of Sao Paulo until 2009 and Full Professor at the Israeli Faculty of Health Sciences Albert Einstein. Superintendent Director of the Israeli Institute of Education and Research Albert Einstein.
MANUELA E. GOMES
Manuela E. Gomes is Associate Professor and President of the I3Bs Research Institute of the University of Minho, Portugal. Her research interests currently focus on tendon tissue engineering strategies, namely in the development of scaffold materials and bioinks based on biodegradable natural origin polymers, stem cells sourcing and differentiation (using biochemical and physical methods). She graduated in Metallurgical and Materials Engineering, University of Porto, Portugal in 1997, obtained a MSc in Polymer Engineering, Univ. of Minho in cooperation with the company Isotis, Bilthoven (Holland), and a PhD in Materials Science and Engineering – Tissue Engineering/Hybrid Materials in collaboration with the Rice University (USA), in 2005. She was a co-founder of the 3B’s Research Group and one of the vice-directors of the group since 2011. Manuela Gomes is a board member of the Doctoral Program on Tissue Engineering, Regenerative Medicine and Stem Cells and is responsible for lecturing on biomaterials, tissue engineering and stem cells to Biomedical Engineering students of the University of Minho. She has been participated in numerous European and national/regional projects as PI or team member. She was awarded a Consolidator Grant from the European Research Council (ERC CoG) to develop magnetically assisted tissue engineering technologies for tendon regeneration and with a EC funded Twinning Project – “Achilles: Overcoming specific weaknesses in tendon biology to design advanced regenerative therapies”, in collaboration with NUI Galway (Ireland), University Regensburg Medical Centre (Germany) and the Mayo Clinic (USA). Manuela Gomes is editor 2 books and co-editor of the Tissue Engineering Encyclopaedia (Elsevier, 2019) and author of 44 book chapters, 200 full papers published in international refereed journals, and more than 300 communications in international conferences (7.900 citations, H-index of 47). She has received several awards, including the 2013 Young Investigator Award of the Tissue Engineering and Regenerative Medicine International Society – European Chapter (TERMIS-EU). Manuela Gomes is an active member of several international scientific organizations, being currently a member-at -large and chair of the membership committee of TERMIS, and Portugal Ambassador for the EORS.
MARCELO PASQUINI
Associate Professor of Medicine, Hematology-Oncology Division at the Medical College of Wisconsin and Attending Physician in the MCW Hematopoietic Cell Transplantation Program. Senior Scientific Director for Clinical Trials, CIBMTR. Scientific Director, CIBMTR Regimen‐Related Toxicity and Supportive Care Working Committee. Scientific Director, CIBMTR Autoimmune Diseases and Cellular Therapies Working Committee. Protocol Officer and Medical Monitor, Blood and Marrow Transplant Clinical Trials Network.
MARCIA MARTINS MARQUES
PhD in Oral Pathology from FOUSP; Pos doc in Cell Biology at the NIH, United States. Full Professor at the FOUSP, at the Ibirapuera University and at the Aachen University, Germany. President elected of ABLOS and member of the ISLD executive board. Her research activity is focused on the effect of photobiomodulation therapy and antibacterial photodynamic therapy.
MARCO AURÉLIO KRIEGER
Graduated in Biological Sciences from the Federal University of Paraná (1987), Master in Biological Sciences (Biophysics) from the Federal University of Rio de Janeiro (1989) and PhD in Biological Sciences (Biophysics) from the Federal University of Rio de Janeiro ( 1997). He is currently a Full Researcher at Fundação Oswaldo Cruz. He has experience in the field of Genetics, with an emphasis on Molecular Parasitology, working mainly on the following themes: Trypanosoma cruzi, gene expression, functional genomics, cell differentiation and use of Molecular Biology techniques for the development of inputs for diagnostic tests.
MARIA ANGÉLICA MIGLINO
Maria Angélica Miglino, professor at the Department of Surgery at FMVZ USP. He received his PhD in 1985 from PPG Functional Anatomy: Structure and Ultrastructure ICB / USP. She was a member of the Fapesp and CNPq Area Committee, in addition to being the Vice-Coordinator and Area Coordinator (Veterinary Medicine) of Capes. He is a member of the Royal Academy of Veterinary Sciences of Spain. Member of the Brazilian Society of Anatomy, World Association of Veterinary Anatomists, and of the American Society of Anatomy. She received awards (Loke Award for Early Care Researchers, IFPA; The EPG Peter Kaufmann New Ivestigator Award; Capes de Tese Award) and most recently the USP-Vida 2020 Award. Cell Therapy in Cancer). CEPID collaborator, Thecnology Transfer Project and Cell Therapy Center. She works in the area of ​​Veterinary Medicine, Morphological Sciences, Developmental Biology with emphasis on Placenta and Placentation, Cell Therapy in Animal Models, and Tissue Engineering, developing multidisciplinary technological projects aimed at the regeneration of organs and tissues.
MARIANA OLIVEIRA
Ms. Oliveira holds a Biology degree from the State University of Campinas (Unicamp) and a Master of Science from the Department of Morphology and Genetics at the Federal University of São Paulo (Unifesp). A passionate scientist has over 10 years of experience in the life science industry and over 6 years of direct business support in the Cell and Gene Therapy market. Currently holds a product specialist title at Cytiva and is the technical responsible for Cell and Gene Therapy in Latin America.
MAROUN KHOURY
Maroun Khoury is currently the Chief Scientific Officer of Cells for Cells and the co-founder of REGENERO: the Chilean Consortium for Regenerative Medicine. He also holds an associate Professor position at the Universidad of the Andes in Santiago, Chile. Maroun Khoury in the immediate past VP for the South and Central America for the International Society for Cellular Therapy (ISCT). He is the co-author of multiple preclinical studies in stem cells and clinical publications including a Phase I/II in heart failure and Osteoarthritis.
MARTIN HERNAN BONAMINO
Graduated in Biological Sciences Medical Modality from the Federal University of Rio de Janeiro (2000) and doctorate in Biological Chemistry from the Federal University of Rio de Janeiro (2004). He is currently a researcher at the National Cancer Institute and a specialist at the Fundação Oswaldo Cruz Foundation, where he participates in the coordination of the FioC Cancer Network. He is a fellow of the Scientist of Our State (CNE) of FAPERJ, a member of the technical working chamber of ANVISA for advanced therapies and of the Global Outreach committee of the American Society of Gene & Cell Therapy. www.martinlab.net.
MASSIMO DOMINICI
Hematologist & oncologist with a strong attitude for research focused on cellular therapies for tissue regeneration and drug delivery. A constant attention to microenvironment cues and their role in influencing biological events in cancer and regenerative medicine. Combining clinical activities and lab, he leads 3 research teams of motivated PhD students and Post-docs to implement cell-gene therapy from the pre-clinic to the clinic. Twenty-nine grants form national and international public & private bodies in 15 years with more than 13 M€ of support. More than 140 peer-revised manuscripts published, 2 edited books, 4 book chapters and 10 patents. One start-up founded: @rigenerand that raised 12 M€ of funds in 3 years. He seeks to treat patients with cells. Currently chair of the @ISCTglobal task force on unproven cell and gene therapies #UnprovenCGT.
MAURO AVANZI
Vice President, Clinical Development at Neogene Therapeutics.
MILDRED C. EMBREE
Assistant Professor of Dental Medicine in orthodontics and, director of the TMJ Biology and Regenerative Medicine Laboratory at Columbia University. Dr. Embree is an orthodontist and cell biologist with over 15 years of experience in the field of osteoarthritis and TMJ. She is a coinventor of StemGEL and a co-Founder and Scientific Advisory Board Chair of Wnt Scientific.
MILTON A RUIZ
Coordinator Department Bone Marrow Transplant, Associação Portuguesa de Beneficência, SJ Rio Preto, SP. Brazil Past VP South and Central America International Society for Cellular Therapy (ISCT). Former Professor Hematology FM USP, SP. Brazil Former Editor Revista Brasileira de Hematologia e Hemoterapia.
MONICA DIUANA CALASANS MAIA
Graduation in Dentistry, Specialist and Master in Oral and Maxillofacial Surgery at Universidade Federal do Rio de Janeiro; PhD in Oral Pathology at Universidade Federal Fluminense; Professor at PPGOdontologia UFF; Member of the Bioengineering Network of the State of Rio de Janeiro; Member of the NanoSaude Network, Faperj Scholarship Holder.
NELSON R. PINTO
Chairman of Research Center for Regenerative Medicine and Tissue Engineering Concepcion, Chile; Facultad de Odontología, Universidad de los Andes, Santiago, Chile; Visiting Professor at Department of Oral Health Sciences / Periodontology; University Hospitals, Catholic University Leuven, Belgium; Developer of Natural Guided Regeneration-Therapy for tissue regeneration and wound healing.
PATRICIA FURTADO MALARD
Graduated in Veterinary Medicine at UFMG (1997). She holds a master‘s degree in Veterinary Medicine from the Federal University of Minas Gerais (2000). She worked as a teacher in the Integrated Faculties of the Planalto Central and in the Faculties of the Land of Brasília. She is currently Professor of Graduate Studies at Instituto Qualittas and Doctoral Student of the Postgraduate Course in Biotechnology at the Catholic University of Brasília. Partner-owner of the BIO Biotechnology in Animal Reproduction and BIO CELL Terapia Celular laboratories, where she holds a management position. Has experience in Biotechnology and Cell Therapy with stem cells.
PATRICIA RIEKEN MACEDO ROCCO
Patricia Rocco, MD, PhD, Vice-President of ISCT for the South and Central America regions, Full Professor at the Federal University of Rio de Janeiro, where she heads the Laboratory of Pulmonary Investigation. Elected Member of the National Academy of Medicine in Brazil and Brazilian Academy of Science. Prof. Rocco has authored and co-authored more than 360 peer-reviewed publications and 120 book chapters.
PAUL TRAVERS
Qualifications Date Awarding body Title of qualification 1979 Oxford University Batchelor of Arts II.1 (Biochemistry) 1983 University of London PhD Current position From (Date) Location Position October, 2007 University of Edinburgh Reader, School of Clinical Sciences Previous Posts held From (Date) Location Position 1984 Consultant Intelligenetics Corp. Palo Alto, California 1984-87 Dept of Medical Microbiology, Stanford University Medical School Research Fellow 1987-98 Dept of Crystallography, Birkbeck College, University of London Royal Society University Research Fellow 1998-2007 Anthony Nolan Research Institute Deputy Director of Research and Reader in Haematology, UCL
PEDRO MORENO PIMENTEL COELHO
He is an Adjunct Professor at the Carlos Chagas Filho Biophysics Institute at UFRJ. He works as an associate researcher at the Laboratory of Comparative and Developmental Neurobiology (https://pesquisa.biof.ufrj.br/neurobiologia/lnbcd/), where he coordinates the Research Group on Experimental Neuropathology (dgp.cnpq.br/dgp/espelhogrupo / 1022226587675588). He is accredited as an advisor by the Graduate Program in Biological Sciences (Physiology) at UFRJ, developing pre-clinical studies and research on the pathophysiology of neurological diseases such as neonatal encephalopathy and hemorrhagic stroke. He acts as a representative of the Adjunct Professors of the Health Sciences Center in the University Council (CONSUNI) of UFRJ. He is a doctor at UFRJ (2007; Cum Laude) and holds a doctorate from the Postgraduate Program in Morphological Sciences at the Institute of Biomedical Sciences at UFRJ (2010). He completed a sandwich doctoral internship (2009) and a postdoctoral position in the research group of Dr. Serge Rivest at Université Laval (Québec, Canada; 2010-2013). He served as 2nd Secretary of the Brazilian Association of Cellular Therapy (ABTCel; 2017-2019), as assistant coordinator (eventual substitute) of the Regenerative Medicine Program (12 / 2017-01 / 2020) and as a member of the Coordination of Scientific Activities (CAC) from the Carlos Chagas Filho Biophysics Institute at UFRJ (2018-2020). Participates in extension activities at Espaço Alexandria at UFRJ. He is a Young Scientist of Our State (FAPERJ), CNPq productivity scholarship holder (level 2, 2020 notice) and member of the Young Medical Leadership Program of the National Academy of Medicine.
PHILIPPE MENASCHÉ
Dr Philippe Menasché obtained his MD and PhD degrees from the University of Paris. He is currently Professor of Thoracic and Cardiovascular Surgery at the University of Paris Descartes, Chief of the Heart Failure Surgery Unit of the Hôpital Européen Georges Pompidou and Director of an INSERM (National Institute of Health and Medical Research) laboratory devoted to cell therapy of cardiovascular diseases. He started to work in this area more than 15 years ago and performed in 2000 the first human intramyocardial transplantation of autologous skeletal myoblasts in a patient with severe heart failure. He was then the PI of a randomised controlled trial of myoblast transplantation designed to assess the safety and efficacy of the technique. The suboptimal results of this study has then led the group to refocus on the use of cardiac progenitors derived from human embryonic stem cells (ESC). The laboratory is using small and large animal (including nonhuman primate) models of myocardial infarction and, in parallel with basic and preclinical studies on myocardial regeneration by ESC-derived cardiac progenitors, is involved in the optimisation of cell delivery and survival-enhancing techniques through the use of tissue engineering with the objective of an upcoming clinical translation in patients with end-stage heart failure who have exhausted conventional therapies.
RAFAEL LINDEN
Graduated in Medicine (1975) and PhD in Biological Sciences (Biophysics, 1979), both from UFRJ, he did postdoctoral studies at Oxford University (1980-1982). He is currently Full Professor at UFRJ (since 1994) and Head of the Neurogenesis Laboratory (since 1985). A pioneer in Brazil in basic research in neurodegeneration and neuroprotection, he created and coordinated the project of the Millennium Institute of Gene Therapy (2005-2008), and is a member of the National Network of Specialists in Advanced Therapies (Reneta) of ANVISA. He is CNPq Researcher 1A, Scientist of Our State at FAPERJ, full member of the Brazilian Academy of Sciences, the Academy of Medicine of Rio de Janeiro, the Academy of Sciences of Latin America and TWAS. He received from the Brazilian Society of Neurosciences and Behavior (SBNeC) the Cesar Timo-Iaria Award for his contributions to Neurosciences and was awarded by the Presidency of the Republic with the Commendation (2001) and the Grand Cross (2007) of the National Order of Merit Scientific.
RENATA MIRANDA PARCA
Graduated in Biological Sciences from the University of Brasilia (2003) and master‘s degree in Animal Biology from the University of Brasilia (2006). She is currently a Specialist in Regulation and Health Surveillance at the National Health Surveillance Agency. She has experience in Physiology, Histology and Microscopy, working mainly on the following topics: nanotechnology, organ and tissue transplantation, assisted human reproduction and stem cells (with emphasis on the health regulation of these services).
RENATO ABDALA KARAM KALIL
Graduated in Medicine at the Federal University of Rio Grande do Sul (1970), Master (1980) and Doctorate (1987) in Medicine: Cardiology, at the Federal University of RS. Full Professor at the Department of Surgical Clinic at UFCSPA (Federal University of Health Sciences of Porto Alegre). Coordinator of the Center for Congenital Heart Diseases at Hospital Moinhos de Vento, as Head of Pediatric Cardiology and Cardiac Surgery. He is a Cardiovascular Surgeon, Researcher and Professor Emeritus of the Postgraduate Program in Cardiology, of the Cardiology Institute of RS - University Foundation of Cardiology (IC-FUC), Institution where he was Coordinator of the Postgraduate Program (Master and Doctorate) of 1999 to 2002, Scientific Director from 2002 to 2011 and Coordinator of the Professional Master‘s Postgraduate Program in Health Research and Innovation Processes from 2013 to 2017; At IC-FUC, he created, among other initiatives, the Laboratory of Molecular and Cellular Cardiology, the Clinical Research Center (CEPEC-FUC) and the Telemedicine Center. Presides over the Cooperative of Cardiovascular Surgeons of Rio Grande do Sul since August 2012; Communication Director (Management 2008-2009) and Research Director (2010-2011) of the Brazilian Society of Cardiology - SBC; Scientific Director of the Brazilian Society of Cardiovascular Surgery (2016-2020); PQ2 researcher at the National Council for Scientific and Technological Development (CNPq). Member of the Advisory Committee of the Medical Area (CA-MD) CNPq (2005-2010). He coordinated the Rio Grande do Sul Cellular Therapy Network (2010-2014), with support from FAPERGS / CNPq / PRONEX. He is a member of the following Scientific Societies: Gaucho Society of Cardiovascular Surgery, Brazilian Society of Cardiovascular Surgery, The Society of Thoracic Surgeons (USA), Society of Cardiology of RGS, Brazilian Society of Cardiology - SBC, American Heart Association, American College of Cardiology and American Association for the Advancement os Science. Member of the Editorial Board of the Brazilian Journal of Cardiovascular Surgery / Brazilian Journal of Cardiovascular Surgery and the Brazilian Archives of Cardiology - SBC. Has experience in Cardiology, working on Cardiovascular Surgery for Adults and Pediatric Cardiac Surgery. Main lines of research: Atrial Fibrillation, Cardiovascular Surgery and Molecular Biology Applied to Cardiology.
RENATO LUIZ GUERINO CUNHA
Graduated in Medicine from the Federal University of Uberlândia School of Medicine (2004), specialization in Clinical Medicine from Hospital das Clínicas Federal University of Uberlândia School of Medicine (2007), in Hematology and Hemotherapy (2009) and Bone Marrow Transplant and Cell Therapy (2010) by the Hospital das Clínicas of the Ribeirão Preto Medical School of the University of São Paulo (HC-FMRP-USP). PhD in Medical Clinic by the Ribeirão Preto School of Medicine at the University of São Paulo and PhD in Cell Therapy and Biotechnology by the University of Paris-Diderot (Paris VII, Paris-France, 2014). Post-doctorate in Bone Marrow Transplantation and Cell Therapy from the National Cancer Institute (ETIB-NCI / NHI) in Bethesda, USA (2015-2018). Since 2019, he is a PhD Professor at the Ribeirão Preto School of Medicine at the University of São Paulo (FMRP-USP) and Coordinator of the Bone Marrow Transplant and Cell Therapy Unit at HC-FMRP-USP. Member of the Brazilian Society of Bone Marrow Transplantation (2009), Brazilian Association of Hematology and Hemoterapi (2009), American College Physician (2015), American Society of Hematology (2016) and American Society for Transplantation and Cellular Therapy (2020). In 2018 he received the ASH Global Research Award and, in 2019, he performed the first treatment with CAR T cells in Latin America, in Ribeirão Preto-Brazil.
RICARDO DE SOUZA TESCH
Graduation in Dentistry at Universidade Federal do Rio de Janeiro; Specialization in Orthodontics, Association of Dental Surgeons of Campinas; Master‘s Degree in Medicine with a concentration in Head and Neck Surgery at Hospital Heliópolis and PhD in Medical Clinic (Neurology) at Universidade Federal do Rio de Janeiro; Professor at Faculdade de Medicina de Petrópolis and Coordinator of the Specialization Course in TMD and Orofacial Pain; Researcher with special interest in the areas of TMD and Orofacial Pain, Headaches, Genetics and Regenerative Medicine, the latter with an emphasis on the use of Cellular Therapies for Cartilage and Bone Regeneration; Principal Investigator in the first human clinical trial for TMJ regeneration using autologous nasal septum chondrocyte transplantation.
ROBERTO GIUGLIANI
Dr. Roberto Giugliani, MD, PhD, is a medical geneticist with specialization in inherited metabolic diseases. He is Full Professor at the Department of Genetics of the Federal University of Rio Grande do Sul, being the founder and active member of the Medical Genetics Service of the University Hospital, in Porto Alegre, Brazil. He is also Editor-in-Chief of the Journal of Inborn Errors of Metabolism and Screening, Chairman of the Latin American School of Human and Medical Genetics (ELAG), and Member of Brazilian Academy of Sciences. He is past President of the Latin American Society of Inborn Errors of Metabolism and Newborn Screening (SLEIMPN), the Latin American Network of Human Genetics (RELAGH), and the Brazilian Society of Medical Genetics and Genomics (SBGM). Prof. Giugliani’s main interests are concentrated in screening, diagnosis, and treatment of inborn errors of metabolism, particularly of lysosomal storage diseases, having supervised the training of over 100 MSc and PhDs, and being author of more than 480 scientific papers.
ROSALIA MENDEZ-OTERO
Medical degree from Federal University of Rio de Janeiro (1977), Master (1980) and PhD (1985) in Biological Sciences from Federal University of Rio de Janeiro. Postdoctoral fellow at Yale University (1985-1987). Faculty member at Federal University of Rio de Janeiro since 1980. Vice-Director of the Carlos Chagas Filho Institute of Biophysics / UFRJ. Founding member and President of the Brazilian Association of Cellular and Gene Therapy (ABTCel). Titular member of the Brazilian Academy of Sciences (ABC) since 2006. National Order of Scientific Merit (2006). Currently Full professor at Federal University of Rio de Janeiro and Head of the Laboratory of Cellular and Molecular Neurobiology. Experience in the area of ​​Neuroscience and Neurology working in basic, pre-clinical and clinical research with cell and gene therapies.
SANG WON HAN
He has a degree in Chemistry, a Master‘s and a PhD in Biochemistry from the University of São Paulo, a post-doctorate in Gene Therapy from the University of Washington and a PhD in Biophysics from the Federal University of São Paulo. He was a professor of biochemistry at Unesp-Rio Claro between 1988-1996, and since 1996 he has been a professor of biophysics at Escola Paulista de Medicina da Unifesp. He is currently a full and active professor in the biophysics department at Unifesp. He was co-founder of the Interdisciplinary Center for Gene Therapy (CINTERGEN) at Unifesp, and was director since its foundation in 2004 until 2010 (the current name of CINTERGEN is CTCMol). He is a member of the Technical Chamber of Advanced Therapies at ANVISA and representative of specialists at RENETA-ANVISA. Since 2019, he has been vice president of the Brazilian Association of Cell and Gene Therapy. The main lines of research are: gene therapy for ischemic and genetic diseases, cancer and DNA vaccine.
SHIRLEY WENKER
Master in Biological Sciences - University of Buenos Aires (2007) and PhD in Biological Chemistry - University of Buenos Aires (2012). She completed a Post-Doctorate at Fundación Instituto Leloir- IIBBA- CONICET in the area of regenerative medicine. She is currently Research Assistant at Fundación Instituto Leloir- IIBBA CONICET, which work subject focus on cell-replacement therapy for Parkinson disease. She teaches classes at School of Sciences -University of Buenos Aires.
VITOR DE CARVALHO MORENO DAS NEVES
Graduation in Dentistry from Brazil and dentist qualified in the UK, who wants to push dentistry forwards through biology. He completed his MSc in Regenerative Dentistry and a PhD in Translational and Regenerative Dentistry at King‘s College London under Prof Paul Sharpe supervision, where he created a dentine self-healing technique fully based on genetic modulation and stem cell activation in the dental pulp. Currently, he holds an NIHR Clinical Lectureship position at KCL and is a Specialty Registrar in Periodontology at Guy‘s Hospital, in London, UK, where he is attempting to enhance periodontal disease prevention.

Promoted by

Management


Support


Virtual Master


Virtual Sponsor


Parceria Virtual